Home LiteratureArticle Details
PMID: 11369431 Published · ppublish English Journal Article Review

HIV fusion and its inhibition.

Antiviral research ·Vol. 50 ·No. 2 ·2001-05-00 ·Pages 95-115

LaBranche CC, Galasso G, Moore JP, Bolognesi DP, Hirsch MS, Hammer SM

Abstract

暂无摘要

MeSH Terms
Anti-HIV Agents/pharmacology,therapeutic use Benzylamines CD4 Immunoadhesins/pharmacology,therapeutic use Cyclams Enfuvirtide HIV/drug effects,physiology HIV Envelope Protein gp41/pharmacology,therapeutic use HIV Infections/drug therapy,virology Heterocyclic Compounds/pharmacology,therapeutic use Humans Membrane Fusion/drug effects Peptide Fragments/pharmacology,therapeutic use Receptors, HIV/drug effects,metabolism
Chemicals
Anti-HIV Agents Benzylamines CD4 Immunoadhesins CD4-IgG(2) Cyclams HIV Envelope Protein gp41 Heterocyclic Compounds Peptide Fragments Receptors, HIV Enfuvirtide plerixafor
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
LaBranche C C
Department of Surgery, Duke University Medical Center, Durham, NC, USA. celia.labranche@duke.edu
Galasso G
Moore J P
Bolognesi D P
Hirsch M S
Hammer S M
Article Info
Journal
Antiviral research
Abbr.
Antiviral Res
ISSN
0166-3542
DOI
10.1016/s0166-3542(01)00130-9
Email
celia.labranche@duke.edu
Published
2001-05-00
Pages
95-115
Language
English
Region
Netherlands
NLM ID
8109699
Subset
IM
External Links
PubMed source DOI: 10.1016/s0166-3542(01)00130-9 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2